Immune-mediated skin diseases including pemphigus foliaceus and lupus erythematosus cause significant welfare problems requiring specialist diagnosis and long-term immunosuppression.
Immune-mediated skin diseases cause chronic discomfort from painful skin lesions, pruritus, and secondary infections. The face and nose are commonly affected, impacting social communication and daily comfort. High-dose immunosuppression causes significant side effects including polyuria, polydipsia, and increased infection susceptibility. Finding the minimum effective dose that maintains remission while minimising side effects is a central welfare management goal. Specialist dermatological input improves outcomes.